Immunophenotypes of G-CSF–mobilized and nonmobilized steady-state normal-donor apheresis products
| . | Positive cells, % (Range) . | |||||||
|---|---|---|---|---|---|---|---|---|
| CD2 . | CD3 . | CD4 . | CD8 . | CD14 . | CD19 . | CD45 . | CD56 . | |
| Baseline | 77.7 ± 1.0 (30-96) | 70.1 ± 1.2 (43-93) | 44.4 ± 1.1 (23-57) | 22.8 ± 0.8 (14-66) | 6.9 ± 1.7 (0.1-4.0) | 12.9 ± 0.7 (0.2-28.0) | 98.8 ± 0.2 (98-100) | 13.4 ± 0.9 (2-65) |
| G-CSF–mobilized | 76.6 ± 1.0 (51-97) | 57.5 ± 3.8 (36-94) | 31.7 ± 2.3 (10-64) | 24.1 ± 2.5 (9-77) | 13.0 ± 5.0 (0.2-7) | 13.5 ± 0.7 (0-38) | 98.6 ± 0.3 (91-100) | 11.8 ± 1.6 (0.5-58) |
| Nonmobilized | ND | 62.6 ± 3.2 (46-79) | 34.2 ± 5.9 (7-61) | 29.9 ± 5.0 (3-64) | 16.9 ± 6.5 (1-57) | 25.7 ± 5.3 (0.2-55) | 98.2 (76-100) | 15.4 ± 3.5 (4-36) |
| . | Positive cells, % (Range) . | |||||||
|---|---|---|---|---|---|---|---|---|
| CD2 . | CD3 . | CD4 . | CD8 . | CD14 . | CD19 . | CD45 . | CD56 . | |
| Baseline | 77.7 ± 1.0 (30-96) | 70.1 ± 1.2 (43-93) | 44.4 ± 1.1 (23-57) | 22.8 ± 0.8 (14-66) | 6.9 ± 1.7 (0.1-4.0) | 12.9 ± 0.7 (0.2-28.0) | 98.8 ± 0.2 (98-100) | 13.4 ± 0.9 (2-65) |
| G-CSF–mobilized | 76.6 ± 1.0 (51-97) | 57.5 ± 3.8 (36-94) | 31.7 ± 2.3 (10-64) | 24.1 ± 2.5 (9-77) | 13.0 ± 5.0 (0.2-7) | 13.5 ± 0.7 (0-38) | 98.6 ± 0.3 (91-100) | 11.8 ± 1.6 (0.5-58) |
| Nonmobilized | ND | 62.6 ± 3.2 (46-79) | 34.2 ± 5.9 (7-61) | 29.9 ± 5.0 (3-64) | 16.9 ± 6.5 (1-57) | 25.7 ± 5.3 (0.2-55) | 98.2 (76-100) | 15.4 ± 3.5 (4-36) |
Values represent mean ± SEM.
G-CSF indicates granulocyte colony-stimulating factor; ND, not done.